Long-Acting Oxytetracycline–Polyethylene Glycol in Horses: Pharmacokinetics and Tolerance

نویسنده

  • Patricia M. Dowling
چکیده

A long-acting oxytetracycline in polyethylene glycol (PEG) was evaluated in a single dose study at 6.6 mg/kg IV and IM and in a long-term dose study at 20 mg/kg IM q 72 h. Pharmacokinetic results were typical for long-acting oxytetracycline formulation. The intramuscular injections caused local irritation, but oxytetracycline-PEG did not alter microbial flora or cause adverse gastrointestinal effects in any horses. Authors’ addresses: Dept. of Veterinary Physiological Sciences (Dowling) and Dept. of Veterinary Microbiology (Chirino-Trejo), Western College of Veterinary Medicine, University of Saskatchewan, 52 Campus Dr., Saskatoon, SK, Canada S7N 5B4. r 1999 AAEP.

برای دانلود رایگان متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید

ثبت نام

اگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید

منابع مشابه

Comparison of the Pharmacokinetics of Conventional and Long- Acting Formulations of Oxytetracycline in Sheep*

The pharmacokinetics of conventional and long-acting oxytetracycline (OTC) formulation were evaluated in sheep at a single dosage of 20 mg-kg-1 body weight (bw). Conventional formulation was injected by intravenous (IV) route and long-acting formulation of oxytetracycline was administered by intramuscular (IM) route. Then blood samples were taken at 0.25, 0.5, 1, 2, 4, 8, 12, 24, 36, 48, 60, 72...

متن کامل

Pharmacokinetics of Conventional and Long-Acting Oxytetracycline Preparations in Kilis Goat

The pharmacokinetics of conventional and long-acting (LA) oxytetracycline (OTC), widely used broad-spectrum antibacterial drugs in veterinary medicine, were evaluated in Kilis goats at single dosage of 20 mg/kg body weight (bw). A total of 21 goats were divided into three groups: intravenous (Group I) and intramuscular (IM) (Group II) administration of the conventional formulation and IM admini...

متن کامل

THROMBOSIS AND HEMOSTASIS Rational design of a fully active, long-acting PEGylated factor VIII for hemophilia A treatment

A long-acting factor VIII (FVIII) as a replacement therapy for hemophilia A would significantly improve treatment options for patients with hemophilia A. To develop a FVIII with an extended circulating half-life, but without a reduction in activity, we have engineered 23 FVIII variants with introduced surface-exposed cysteines to which a polyethylene glycol (PEG) polymer was specifically conjug...

متن کامل

Rational design of a fully active, long-acting PEGylated factor VIII for hemophilia A treatment.

A long-acting factor VIII (FVIII) as a replacement therapy for hemophilia A would significantly improve treatment options for patients with hemophilia A. To develop a FVIII with an extended circulating half-life, but without a reduction in activity, we have engineered 23 FVIII variants with introduced surface-exposed cysteines to which a polyethylene glycol (PEG) polymer was specifically conjug...

متن کامل

Fabrication of Clotrimazole microparticles using polyethylene glycol 6000 and beeswax

Backgrounds: Microparticles are one of drug delivery systems designed for sustained and controlled release of drugs for a long period of time. Clotrimazole is a broad-spectrum antifungal agent, which is generally used for treatment of Candida albicans and others fungal infections. Objectives: The present study aims to fabricate Clotrimazole microparticles using beeswax (lipophilic coating) an...

متن کامل

ذخیره در منابع من


  با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید

عنوان ژورنال:

دوره   شماره 

صفحات  -

تاریخ انتشار 1999